Translating trial results into interpretable risk estimates: systematic analysis of cardiorenal outcome trials of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors
Rizzi A, Kloecker DE, Pitocco D, et al.
NMCD. Pub. online 19 Dec 2023.
Leggi